LA
BIO icon

LBP AM’s Bio-Rad Laboratories Class A BIO Stock Holding History

LBP AM’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,264
Closed -$1.04M – 371
2025
Q1 		$1.04M Sell
4,264
-133
-3% -$40K 0.02% 315
2024
Q4 		$1.44M Buy
+4,397
New +$1.49M 0.02% 298
2024
Q1 		– Sell
-33,135
Closed -$10.7M – 333
2023
Q4 		$10.7M Hold
33,135
– – 0.24% 104
2023
Q3 		$11.9M Buy
33,135
+825
+3% +$318K 0.26% 101
2023
Q2 		$12.2M Sell
32,310
-5,700
-15% -$2.32M 0.29% 87
2023
Q1 		$18.2M Buy
38,010
+2,000
+6% +$936K 0.46% 68
2022
Q4 		$15.1M Buy
+36,010
New +$14.5M 0.43% 63

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

LBP AM's BIO Position: Q2 2025 in Review

LBP AM sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 4,264 shares — an estimated $1.04M sold.

LBP AM first reported a position in BIO in Q4 2022 and held it in 7 quarters. The position peaked at $18.2M in Q1 2023. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • LBP AM reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
  • LBP AM sold 4,264 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $1.04M.
  • LBP AM first reported a position in Bio-Rad Laboratories Class A in Q4 2022 and held it in 7 quarters.
  • LBP AM's Bio-Rad Laboratories Class A position peaked at $18.2M in Q1 2023.
  • 384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on LBP AM's 13F filing for Q2 2025, filed 18 Jul 2025.